Rezolute stock crashes after sole pipeline candidate fails Phase III
Rezolute’s stock has crashed after its only pipeline product flopped in a Phase III trial. In the sunRIZE trial (NCT06208215),…
News
Lilly’s triple G agonist boasts 28.7% weight loss in Phase III trial
FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
GRI Bio’s tazarotene achieves Phase IIa IPF success
UK MHRA clears Ensoma’s EN-374 trial application for X-CGD
EpilepsyGTx secures $33m to progress FRE therapy through Phase I/IIa trials
BioNTech and BMS’ bispecific touts 59.3% nine-month PFS in TNBC
